Trial Profile
Phase II study of adjuvant S-1 concurrent radiotherapy in pancreatic cancer patients with high risk factors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 22 Feb 2013 New trial record